Best Leonard
Department of Medicine, University of Manchester, Oxford Road, Manchester M13 9WL, UK.
Cell Signal. 2002 Jan;14(1):69-73. doi: 10.1016/s0898-6568(01)00223-6.
The antioestrogen 4-hydroxytamoxifen (10 or 2 microM) abolished the generation of action potentials and repolarized the membrane potential in rat pancreatic beta-cells stimulated by 16 mM glucose. This effect was slowly reversible upon withdrawal of the drug. In cells stimulated by tolbutamide (100 microM), application of 4-hydroxytamoxifen again inhibited action-potential generation but failed to repolarize the membrane potential. 4-Hydroxytamoxifen inhibited voltage-sensitive calcium currents and activity of the volume-sensitive anion channel. The drug had no effect on net K(+) conductance of the cell. Insulin release stimulated by either glucose or tolbutamide was inhibited by 4-hydroxytamoxifen. It is concluded that 4-hydroxytamoxifen impairs beta-cell electrical and secretory activity by inhibiting calcium and anion channel currents. This effect could contribute towards hyperglycaemia during therapy with tamoxifen, of which 4-hydroxytamoxifen is the major metabolite. This study also reveals differences between the depolarizing actions of glucose and tolbutamide in the beta-cell.
抗雌激素4-羟基他莫昔芬(10或2微摩尔)可消除16毫摩尔葡萄糖刺激的大鼠胰腺β细胞动作电位的产生,并使膜电位复极化。撤药后这种效应可缓慢逆转。在甲苯磺丁脲(100微摩尔)刺激的细胞中,应用4-羟基他莫昔芬再次抑制动作电位的产生,但未能使膜电位复极化。4-羟基他莫昔芬抑制电压敏感性钙电流和容积敏感性阴离子通道的活性。该药物对细胞的净钾离子电导无影响。4-羟基他莫昔芬抑制由葡萄糖或甲苯磺丁脲刺激引起的胰岛素释放。结论是,4-羟基他莫昔芬通过抑制钙和阴离子通道电流损害β细胞的电活动和分泌活动。这种效应可能导致他莫昔芬治疗期间的高血糖,其中4-羟基他莫昔芬是主要代谢产物。本研究还揭示了葡萄糖和甲苯磺丁脲在β细胞中的去极化作用之间的差异。